Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2010-7-16
pubmed:abstractText
The prospective study was designed to clarify the impact of CYP2C19 on quadruple therapies and survey the efficacies of rabeprazole-based quadruple therapy for Helicobacter pylori infection after failure of standard triple therapies.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1523-5378
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
265-72
pubmed:meshHeading
pubmed-meshheading:20633187-2-Pyridinylmethylsulfinylbenzimidazoles, pubmed-meshheading:20633187-Adult, pubmed-meshheading:20633187-Aged, pubmed-meshheading:20633187-Anti-Bacterial Agents, pubmed-meshheading:20633187-Anti-Ulcer Agents, pubmed-meshheading:20633187-Aryl Hydrocarbon Hydroxylases, pubmed-meshheading:20633187-Drug Resistance, Bacterial, pubmed-meshheading:20633187-Drug Therapy, Combination, pubmed-meshheading:20633187-Female, pubmed-meshheading:20633187-Helicobacter Infections, pubmed-meshheading:20633187-Helicobacter pylori, pubmed-meshheading:20633187-Humans, pubmed-meshheading:20633187-Male, pubmed-meshheading:20633187-Middle Aged, pubmed-meshheading:20633187-Omeprazole, pubmed-meshheading:20633187-Prospective Studies, pubmed-meshheading:20633187-Proton Pump Inhibitors, pubmed-meshheading:20633187-Young Adult
pubmed:year
2010
pubmed:articleTitle
Rabeprazole can overcome the impact of CYP2C19 polymorphism on quadruple therapy.
pubmed:affiliation
Division of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung, Taiwan.
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't